Co-Authors
This is a "connection" page, showing publications co-authored by Marco Caminati and Gianenrico Senna.
Connection Strength
9.760
-
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? Vaccines (Basel). 2021 Jan 11; 9(1).
Score: 0.923
-
Targeting eosinophils: severe asthma and beyond. Drugs Context. 2019; 8:212587.
Score: 0.834
-
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy. World Allergy Organ J. 2019; 12(7):100046.
Score: 0.831
-
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic. Biologics. 2019; 13:89-95.
Score: 0.824
-
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life. Immunotherapy. 2019 06; 11(9):783-794.
Score: 0.823
-
Biologic Therapy in a Patient with Asthma and Nasal Polyps. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1700-1701.
Score: 0.821
-
Uncontrolled severe asthma: starting from the unmet needs. Curr Med Res Opin. 2019 02; 35(2):175-177.
Score: 0.793
-
Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation. Ann Allergy Asthma Immunol. 2017 Nov; 119(5):460-462.
Score: 0.734
-
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control. Vaccines (Basel). 2021 Aug 04; 9(8).
Score: 0.240
-
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic. World Allergy Organ J. 2021 Feb; 14(2):100515.
Score: 0.232
-
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021 01; 176:106261.
Score: 0.229
-
Editorial: Reconsidering anaphylaxis at the time of COVID-19 pandemic. Curr Opin Allergy Clin Immunol. 2020 10; 20(5):429-430.
Score: 0.226
-
BCG vaccination and COVID-19: Much ado about nothing? Med Hypotheses. 2020 11; 144:110109.
Score: 0.223
-
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases. J Allergy Clin Immunol. 2020 09; 146(3):541-542.
Score: 0.222
-
Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice. J Investig Allergol Clin Immunol. 2018 Aug; 28(4):273-275.
Score: 0.195
-
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients. J Asthma. 2018 09; 55(9):1028-1034.
Score: 0.185
-
Evaluation of asthma control in the pharmacy: an Italian cross-sectional study. Eur Ann Allergy Clin Immunol. 2017 Sep; 49(5):225-230.
Score: 0.183
-
Asthma management among allergists in Italy: results from a survey. Clin Mol Allergy. 2017; 15:11.
Score: 0.179
-
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. Clin Mol Allergy. 2017; 15:9.
Score: 0.178
-
Fatal asthma; is it still an epidemic? World Allergy Organ J. 2016; 9(1):42.
Score: 0.174
-
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Rev Clin Immunol. 2015 Feb; 11(2):233-45.
Score: 0.151
-
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship? Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):411-417.
Score: 0.061
-
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19. Diagnostics (Basel). 2021 Mar 12; 11(3).
Score: 0.058
-
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
Score: 0.056
-
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation. Allergy. 2019 12; 74(12):2539-2541.
Score: 0.052
-
Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience. World Allergy Organ J. 2019; 12(4):100032.
Score: 0.051
-
Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey. Clin Mol Allergy. 2019; 17:2.
Score: 0.051
-
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report. J Investig Allergol Clin Immunol. 2018 Aug; 28(4):285-286.
Score: 0.049
-
Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population. J Asthma. 2019 01; 56(1):27-33.
Score: 0.047
-
Anaphylaxis and intimate behaviour. Curr Opin Allergy Clin Immunol. 2017 Oct; 17(5):350-355.
Score: 0.046
-
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):208-218.
Score: 0.046
-
Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain. World Allergy Organ J. 2017; 10(1):13.
Score: 0.044